52W Range | $0.85-$40.50 |
Market Cap | $116.2M |
Shares Short | 77,332 |
Revenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
CEO | Mr. Leonard L. Mazur |
CFO | Mr. Jaime Bartushak |
Address | 420 Lexington Avenue, New York, NY, United States, 10170 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 0 |